Insiders · Profile

Pauls Matthew

Director at Pelthos Therapeutics · CHIEF EXECUTIVE OFFICER at Savara. Filing since 22 Feb 2021. CIK 0001573429

Company
Date
Role
Action
Shares
Amount
Of holding
2 Oct 2026
Director
Sold on a plan
786
$16.51K
5.5%
2 Jul 2026
Director
Sold on a plan
786
$20.56K
5.2%
2 Apr 2026
Director
Sold on a plan
786
$16.44K
4.9%
16 Dec 2024
CHIEF EXECUTIVE OFFICER
Sold at will
54,702
$180.83K
3.4%
28 Dec 2023
CHIEF EXECUTIVE OFFICER
Sold at will
84,000
$395.90K
6.1%
8 Dec 2021
CHIEF EXECUTIVE OFFICER
Bought
6,500
$6.89K
1.7%
2 Dec 2021
CHIEF EXECUTIVE OFFICER
Bought
10,000
$10.95K
2.7%
19 Nov 2021
CHIEF EXECUTIVE OFFICER
Bought
12,150
$13.39K
3.4%
18 Nov 2021
CHIEF EXECUTIVE OFFICER
Bought
10,000
$11.00K
2.9%
18 Aug 2021
CHIEF EXECUTIVE OFFICER
Bought
11,900
$14.17K
3.6%
17 Aug 2021
CHIEF EXECUTIVE OFFICER
Bought
15,000
$17.70K
4.7%
21 May 2021
CHIEF EXECUTIVE OFFICER
Bought
10,000
$16.30K
3.2%
19 Apr 2021
CHIEF EXECUTIVE OFFICER
Bought
27,400
$49.87K
9.8%
22 Mar 2021
CHIEF EXECUTIVE OFFICER
Bought
24,100
$49.94K
9.4%
22 Feb 2021
CHIEF EXECUTIVE OFFICER
Bought
28,700
$50.04K
12.6%
15 decisions on file.